Abridge
🔥 HOTHow Abridge stacks up in AI Healthcare — funding data, key investors, and more.
Updated Mar 23, 2026Awaira Score
Out of 100
HQ
United States
Founded
2018
Raised
$800M
Stage
Series E
Team
120
Valuation
$5.3B
Post-money
Total Raised
$800M
All rounds
Awaira Score
76/100
Founded
2018
120 employees
Awaira estimate based on public data. Not financial advice.
About Abridge
Abridge is an AI health company founded in 2018 that develops clinical documentation and conversation intelligence tools for healthcare providers. The company's core product uses artificial intelligence to automatically generate clinical notes from patient-physician conversations, addressing the administrative burden that consumes significant physician time. Abridge's technology uses natural…
Is this your company? Claim it →Strengths & Risks
Strengths
Unicorn status with $5.3B valuation
Strong Awaira Score of 76/100
Growing team of 120 employees
Analysis based on publicly available data. Not investment advice.
Market Position
Abridge is a AI unicorn in the AI Healthcare sector. Founded in 2018, the company is currently at the Series E stage with a team of approximately 120 employees. With $800M in total disclosed funding, Abridge has demonstrated the ability to attract institutional capital. The company competes with 3 other tracked AI Healthcare companies on Awaira, including Butterfly Network and Tempus.
Key Numbers
Awaira Score
76/100
Valuation
$5.3B
Total Funding
$800M
Founded
2018
Employees
120
Stage
Series E
Funding Velocity
4
Total Rounds
$69M
Avg Round Size
4.1yr
Funding Span
Abridge raised 4 rounds over 4.1 years, averaging $69M per round — a pace of roughly one round every 12 months.
Why Track Abridge?
Abridge holds unicorn status in the AI Healthcare space, placing it among the highest-valued private AI companies globally.
Among 3 tracked competitors, Abridge ranks #3 by valuation — a metric investors and analysts use to gauge market standing.
Tracking Abridge on Awaira provides real-time updates on funding rounds, investor activity, and competitive moves in the AI Healthcare market.
Competitor Comparison
| Metric | ★Abridge | Butterfly Network | Tempus | Alan |
|---|---|---|---|---|
| Awaira Score | 76/100 | 85/100 | 84/100 | 83/100 |
| Total Raised | $800M | $370M | $1.05B | $750M |
| Valuation | $5.3B | $957M | $8.1B | $5.83B |
| Stage | Series E | Public | Public | Series D |
| Founded | 2018 | 2011 | 2015 | 2016 |
| Employees | 120 | 500-1000 | 2500 | 500-1000 |
| Country | 🇺🇸 | 🇺🇸 | 🇺🇸 | 🇫🇷 |
Investors in Abridge
Funding Rounds
InactiveKleiner Perkins, Lerer Hippeau, Khosla Ventures
$150M
Jan 2023
$30M
Jan 2022
Kleiner Perkins, Khosla Ventures
$27M
Jan 2021
Undisclosed
Jan 2019
Open Positions at Abridge
View all jobs →Abridge Latest News
Compare Abridge
See how Abridge stacks up against competitors in valuation, funding, team size, and Awaira Score.
Founded Same Year (2018)
Similar by Funding Stage (Series E)
More from United States
🇺🇸 View all AI companies in United States →Alternatives
View all alternatives to Abridge →